HTGF and Bayern Kapital back Photonics Healthcare

Photonics will use the fresh capital to develop and test a monitor, which allows the measuring of cellular oxygen. 

The German venture capital firm HTGF usually invests around €500,000 in each transaction. The GP currently manages two funds: the €272m Fonds I and the €301.5m Fonds II.

Photonics is HTGF's eighth investment in the medical equipment sector so far this year. In September this year, HTGF backed perora, a manufacturer of medical devices for the treatment of obesity and type II diabetes.

HTGF also invested in NovaPump, a developer of transcatheter heart valve technology, in a series-A funding round in July 2013.

Bayern Kapital typically invests €250,000-600,000 in each portfolio company. The Bavarian venture firm has backed one medial equipment company so far this year, when it invested €1m in German Medical Engineering, a laser and light system manufacturer, alongside HTGF and BayBG in April.

Company
Photonics aims to commercialise the measuring of cellular oxygen, with its latest product being the Comet monitor, which allows doctors to optically measure the oxygen in the mitochondria inside a patient's cells and thus adjust treatment accordingly.

The company is based in Munich with an additional office in Rotterdam, Netherlands.

People
Michael Münker is co-founder and managing director of Photonics. Ron Winkler is investment manager at HTGF and led the deal. Andreas Huber is senior investment manager at Bayern Kapital and led the deal for the Bavarian VC.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Early-stage
• Healthcare
• Germany
• High-Tech Gründerfonds